NCT07446322 2026-03-04FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal CancerOncolytics BiotechPhase 2 Not yet recruiting60 enrolled